News

Biomarkers are small molecules that indicate the presence of a particular physiological condition, typically a disease. The new method, if successful, could prove useful not just for identifying

Idenix Pharmaceuticals (Idenix) has initiated a phase II randomised, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and antiviral activity of IDX184 in combination with

GlaxoSmithKline (GSK) and Pfizer have launched ViiV Healthcare, a new specialist HIV company. The newly launched firm aims to tackle the increasingly diverse and complex needs of people

Lonza has enhanced its protein design technology offering for biopharmaceutical development by acquiring Algonomics. Effective November 2, 2009, Lonza has acquired all shares of Algonomics including the proprietary

GATC Biotech is set to open a sequencing laboratory in London to provide scientists in UK and Ireland with single sample sequencing services. It will be situated in

MeadWestvaco (MWV) has appointed Alejandro Cedeno as vice president of global innovation. In this new role, Mr Cedeno will be located at MWV’s Center for Packaging Innovation (CPI)

The French patient advocacy organisation, Association Française contre les Myopathies (AFM) has awarded a grant of CHF1m for the development of Santhera Pharmaceuticals’ (Santhera) SNT-317 (INN: omigapil) in

Sigma-Aldrich has entered into a worldwide licensing agreement with Polyplus-transfection to manufacture and commercialize Zip Nucleic Acid (ZNA)oligonucleotides, a new technology that provides solutions for increased affinity for

Amylin Pharmaceuticals (Amylin) and Eli Lilly have issued statement in response to the FDA update on Byetta (exenatide) injection. On October 30, the FDA approved an expanded indication